ScreenPro FH - Screening Project for Familial Hypercholesterolemia in Central, Southern and Eastern Europe: Rationale and Design

Familial hypercholesterolemia (FH) is a genetic disorder with well-known genetic transmission and clinical course. Despite great recent progress, FH is still underestimated, under-diagnosed and thus undertreated. Furthermore it represents a significant healthcare challenge as a common risk factor fo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vnitřní lékar̆stvĭ 2017, Vol.63 (1), p.43-48
Hauptverfasser: Češka, Richard, Paragh, György, Reiner, Željko, Banach, Maciej, Tokgözoğlu, Lale, Susekov, Andrey V, Rašlová, Katarína, Freiberger, Tomáš, Vohnout, Branislav, Rynkiewicz, Andrzej, Goudev, Assen, Dan, Gheorghe-Andrei, Gaiţă, Dan, Pojskić, Belma, Pećin, Ivan, Kayıkçıoğlu, Meral, Mitchenko, Olena, Ezhov, Marat V, Latkovskis, Gustavs, Petrulionienė, Žaneta, Fras, Zlatko, Tasić, Nebojsa, Mirrakhimov, Erkin M, Murataliev, Tolkun, Shek, Alexander B, Tuka, Vladimír, Tselepis, Alexandros D, Moubarak, Elie M, Rasadi, Khalid Al
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Familial hypercholesterolemia (FH) is a genetic disorder with well-known genetic transmission and clinical course. Despite great recent progress, FH is still underestimated, under-diagnosed and thus undertreated. Furthermore it represents a significant healthcare challenge as a common risk factor for the premature development of coronary heart disease. The ScreenPro FH Project is an international network project aiming at improving complex care - from timely screening, through diagnosis to up-to-date treatment of familial hypercholesterolemia in Central, Eastern and Southern Europe. An important task for the project is to harmonise and unify diagnostic and therapeutic approaches in participating countries, where the situation differs from country to country. Countries with more experience should serve as a model for countries developing the FH network.Key words: diagnosis - familial hypercholesterolemia - screening - treatment optimization.
ISSN:0042-773X
1801-7592
DOI:10.36290/vnl.2017.008